Safety and efficacy of the AngioJet device in the treatment of thrombosed arteriovenous fistula and grafts: A systematic review

Chan, Philip; Goh, Gerard S

doi:10.1177/1129729818760977

Cited by 27 publications

(28 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There are treatment methods of thrombotic occlusion in VA currently in the main stream such as surgical thrombectomy, thrombolysis device, thrombus fragmentation device or thrombus suction device, and so on. These methods show a good result for a long period as in the previous works, 5–10 but, except for surgical thrombectomy, they require medical treatment during the hyperacute phase after obstruction. Fragmentation will be impossible when time passed after obstruction as the thrombus degenerates and stiffens.…”

Section: Discussionmentioning

confidence: 62%

Ultrasound-guided removal of organized thrombi using biopsy forceps in dialysis patients with arterio-venous access occlusion

Wakabayashi¹

2019

J Vasc Access

View full text Add to dashboard Cite

Introduction: As a countermeasure against the organized thrombi frequently observed in vascular access occlusion, we devised a percutaneous excision method for organized thrombi under superficial ultrasound guidance using biopsy forceps. The Radial JawTM 3 (2 mm) biopsy forceps of Boston Scientific Corporation was used. The usefulness of this method was investigated. Method: The following protocol, which is suitable for endovascular treatment, was prepared and used: (1) all procedures were performed under ultrasound guidance and (2) use of the forceps was assisted via a long sheath in cases involving a complicated bloodstream. Subjects: Among 564 cases of arterio-venous access occlusion that received treatment at this hospital between May 2014 and April 2017, the subjects of this study were 468 cases who could be followed up. Thrombectomy of an organized thrombus using the biopsy forceps was performed 194 times in 138 cases. Biopsy forceps were used in the initial treatment in a total of 115 cases, including 71 cases of acute occlusion of an autologous vein, 3 cases of chronic occlusion of an autologous vein, and 41 cases of acute occlusion of a prosthetic vessel. Results: The initial success rate for all cases of occlusion was 97.2%. The initial success rate for cases in which biopsy forceps were used was 98.2%. For cases using biopsy forceps, the primary patency rates were 47.1% at 3 months, and the secondary patency rates (until occlusion) were 89.1% at 3 months. Conclusion: This method was considered to be a valuable choice as a countermeasure against organized thrombi.

show abstract

Section: Discussionmentioning

confidence: 62%

Ultrasound-guided removal of organized thrombi using biopsy forceps in dialysis patients with arterio-venous access occlusion

Wakabayashi¹

2019

J Vasc Access

View full text Add to dashboard Cite

show abstract

“…Mechanical thrombectomy and catheter-directed thrombolysis were reported to be effective and safe techniques for endovascular graft thrombectomy. 4,[6][7][8][9][10] Catheter aspiration, which accounted for 80% of the endovascular procedures performed in our study, is a simple and effective technique that requires no expensive surgical devices, but it yields comparable results relative to procedure success rate and graft patency.…”

Section: Discussionmentioning

confidence: 76%

“…Mostly of patients had total graft thrombosis, only 11 of 25 patients in the endovascular group presented with clinical partial graft thrombosis. Median time from graft thrombosis to treatment was 2 days (range: 1-14) in the endovascular group, and 1 day (range: [1][2][3][4][5][6][7][8][9][10][11][12][13][14] in the open thrombectomy group (p=0.078). A summary of patient and graft data is shown in Table 1.…”

Section: Resultsmentioning

confidence: 99%

Endovascular thrombectomy versus open surgical thrombectomy for thrombosed arteriovenous hemodialysis graft

Puangpunngam

2019

Smj

View full text Add to dashboard Cite

The aim of this study was to investigate the procedure success rate, one-year primary patency rate, one-year secondary patency rate, and complications compared between endovascular therapy and open surgical thrombectomy for treatment of thrombosed arteriovenous hemodialysis graft. Methods: This retrospective chart review included patients with thrombosed arteriovenous hemodialysis graft who were treated at the

show abstract

“…Experience with this system in occluded vascular access is relatively limited though, especially in native AVF, with varying clinical success and patency rates . Moreover, the quality of the evidence fluctuates …”

Section: Introductionmentioning

confidence: 99%

“…[2][3][4][7][8][9][10][11][12] Moreover, the quality of the evidence fluctuates. 13 The aim of this study was to review our 8-year experience in endovascular mechanical thrombectomy using the AngioJet™ system in patients with AVF and AVG, and to determine whether this can be deemed an effective technique. Outcomes were technical and clinical success and patency rates.…”

Section: Introductionmentioning

confidence: 99%

Outcomes after endovascular mechanical thrombectomy in occluded vascular access used for dialysis purposes

Drouven

Bruin

Roon

et al. 2020

Cathet Cardio Intervent

View full text Add to dashboard Cite

Purpose Endovascular mechanical thrombectomy using the AngioJet™ system can be considered to reestablish patency in occluded vascular access. The aim of this study was to review our results for endovascular mechanical thrombectomy using the AngioJet™ system in patients with arteriovenous fistulae (AVF) and arteriovenous grafts (AVG). Methods Data collected in a database of patients requiring hemodialysis for renal failure were analyzed. Patients who underwent endovascular mechanical thrombectomy procedures with the AngioJet™ system for occlusion of vascular access were included. Clinical and technical success rates and patency rates were calculated. Multivariate analysis was used to identify factors of influence. Results A total of 92 AngioJet™ procedures in 60 patients with thrombosed vascular access were reviewed during a mean follow‐up period of 21.5 months in patients with an AVF and 11.9 months in patients with an AVG. Technical and clinical success was achieved in 92.6% of AVF cases and 92.0 and 90.8% of AVG cases with an AVG, respectively. Significantly higher primary and primary‐assisted patency rates were observed in the AVF group. Multivariate regression analysis indicated that left‐sided vascular access and female sex were independent predictors for failure regarding primary patency in AVG patients. Immunosuppressive drugs and older age were negative predictors for secondary patency in AVG patients. Conclusions The AngioJet™ system can be deemed an effective technique to reestablish patency in occluded vascular access with minimal use of central venous catheters for dialysis. Good technical and clinical success rates were achieved with acceptable patency rates, especially in AVF patients.

show abstract

Safety and efficacy of the AngioJet device in the treatment of thrombosed arteriovenous fistula and grafts: A systematic review

Cited by 27 publications

References 29 publications

Ultrasound-guided removal of organized thrombi using biopsy forceps in dialysis patients with arterio-venous access occlusion

Ultrasound-guided removal of organized thrombi using biopsy forceps in dialysis patients with arterio-venous access occlusion

Endovascular thrombectomy versus open surgical thrombectomy for thrombosed arteriovenous hemodialysis graft

Outcomes after endovascular mechanical thrombectomy in occluded vascular access used for dialysis purposes

Contact Info

Product

Resources

About